Short answer
Aveanna Healthcare Holdings, Inc. (AVAH) filed an 8-K current report with the SEC on November 13, 2026 reporting Item 7.01 (Regulation FD Disclosure), Item EX-99.1 (Exhibit EX-99.1). Aveanna released an investor financial presentation on November 13, 2026, potentially updating operating and financial outlook.
Aveanna Healthcare Holdings, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 7.01 · Regulation FD Disclosure
- Aveanna released an investor financial presentation on November 13, 2026, potentially updating operating and financial outlook
- Exhibit 99.1 contains the substantive presentation, requiring review for guidance, results, and strategic updates
- Website distribution signals investor-relations materials may provide time-sensitive information beyond SEC filings
Item EX-99.1 · Exhibit EX-99.1
- November 2026 presentation raises 2026 guidance above $2.695B revenue and $374M Adjusted EBITDA
- Q3 revenue $695.5M, up 11.8%, while Adjusted EBITDA reached $100.1M, up 25.0%
- Positive 2026 free cash flow of $141.2M, improving $55.0M versus 2025, supports deleveraging or acquisitions
- Liquidity $492.1M against $1,521.3M variable-rate debt, creating material interest-rate and refinancing sensitivity
- Long-term growth targets: 5%–7% organic growth, 8%–11% M&A growth, and 3%–4% platform efficiencies
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Aveanna Healthcare Holdings, Inc. 8-K filings
Get the next AVAH 8-K as it lands
Follow AVAH for push alerts, or ask the research agent what this filing means.